IPO on the open market — Innoscripta Software valued in the billions

Munich — The issue price of Inno­scripta shares was 120 euros, which was at the lower end of the targe­ted price range of 110 to 140 euros. Accor­ding to Inno­scripta, a total of 1.82 million shares were sold. For the foun­ders, owners and board members Michael Hohe­nes­ter and Alex­an­der Meyer, this means proceeds of 218 million euros. Mean­while, the company itself will not receive any cash inflows from the IPO. 

The enter­prise value was set at EUR 1.2 billion as part of the IPO.

Compli­ance soft­ware in focus

Inno­scripta is a soft­ware company that specia­li­zes in cloud-based compli­ance soft­ware for rese­arch and deve­lo­p­ment. The newco­mer to the stock market claims to be the market leader in this field and as such is “active in advi­sing compa­nies from various sectors on tax-rela­­ted rese­arch funding” for the successful manage­ment and docu­men­ta­tion of their rese­arch and deve­lo­p­ment projects. 

“Our vision is to be the worl­d’s leading provi­der of R&D manage­ment solu­ti­ons and to trans­form the way compa­nies inno­vate and grow. We strive to create a world where breakth­rough ideas are seam­lessly brought to life through advan­ced tech­no­logy and opti­mi­zed proces­ses. By conti­nuously impro­ving our plat­form and expan­ding our reach, we aim to help compa­nies and indus­tries realize their full poten­tial, drive progress and make a lasting impact on the world,” the company said. 

Inno­scripta opera­tes profitably

Busi­ness has been going very well at Inno­scripta recently. In 2024, the company gene­ra­ted reve­nue of EUR 64.7 million, compared to reve­nue of EUR 39.4 million in the previous year. Inno­scripta is also profi­ta­ble: EBIT rose from 15.15 million euros in 2023 to 37.3 million euros in 2024. 

The stock market plans were supported by Beren­berg, Hauck Aufhäu­ser and M.M. Warburg.

www.innoscripta.com/de

Second IPO on the OTC market

Inno­scripta is the second company within a few weeks to go public on the Frank­furt Stock Exch­ange in the “Scale” OTC segment. Pfis­terer had previously cele­bra­ted its stock market debut and impres­sed inves­tors. The initial price was above the issue price, and the Pfis­terer share has contin­ued to trade at this level ever since.